重磅新品 | 擁有NMPA三類注冊(cè)證書，自研生產(chǎn)的Hp-IgG正式被國(guó)家藥監(jiān)局批準(zhǔn)上市
時(shí)間：2024-02-23 瀏覽次數(shù)：
次
[1] 國(guó)際癌癥組織. 2020中國(guó)癌癥死亡人數(shù)統(tǒng)計(jì)[EB/OL].[2024-1-5][2] Katai H,lshikawa T,Akazawa K,et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric CancerAssociation (2001-2007)[J].Gastric Cancer,2018,21(1):144-154.[3] Sumiyama K. Past and current trends in endoscopic diagnosis for early stage gastric cancer in Japan[J].Gastric Cancer,2017,20(1):20-27.[4] 中國(guó)早期胃癌篩查流程專家共識(shí)意見（草案2017年，上海）
